Skip to main content

Table 2 Baseline characteristics of the cohort population with IFG and non-IFG

From: Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study

Variable IFG (N =442) Non-IFG(N =4,484) P-value
Age 53.37±14.26 43.99±14.59 <0.0001
Sex    <0.0001
Male 286 2,348  
Female 156 2,136  
Height 163.70±8.39 163.80±8.21 0.7064
Weight 66.02±11.24 61.89±11.15 <0.0001
BMI 24.54±3.06 22.95±2.99 <0.0001
WC 83.29±8.74 78.70±9.07 <0.0001
SBP 131.30±19.78 120.50±17.21 <0.0001
DBP 79.00±11.75 73.84±10.97 <0.0001
TC 5.02±0.97 4.75±0.90 <0.0001
TG 1.88±1.58 1.38±0.96 <0.0001
HDL-C 1.39±0.37 1.46±0.35 <0.0001
LDL-C 3.02±0.82 2.84±0.80 <0.0001
Blood urea 5.37±1.33 5.03±1.33 <0.0001
SCr 73.87±14.99 70.29±16.27 <0.0001
SUA 352.90±80.42 327.60±86.09 <0.0001
  1. Abbr: IFG Impaired fasting glucose, BMI Body mass index, WC Waist circumference, SBP Systolic Blood pressure, DBP Diastolic Blood pressure, TC Total cholesterol, TG Triglycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, SCr Serum creatinine, SUA Serum uric acid